Write For Us

COVID-19 Vaccine Update | Dhruv Rathee

Google Rank
Some really great news is coming from the scientists working on development of COVID-19 vaccine. There are two potential vaccines from Pfizer and Moderna who have successfully conducted phase 3 trials and have shown to have more than 95% effectiveness. In this video, I explain and interview India's leading vaccine expert Dr. Gagandeep Kang. Full interview will be available exclusively for Patron and Youtube Members.

Link to my Spotify Episode: https://link.tospotify.com/nVuaV7KZFbb

Kuvera App download: http://bit.ly/30rHNQO
Kuvera is India’s First Free Direct Mutual Fund and Gold Investing Platform. Experience simplified investing in mutual funds with Zero Fee and Higher Returns!

Support my work and join as a member to get exclusive stuff:
1. On Patreon: https://www.patreon.com/dhruvrathee
2. On Youtube: https://www.youtube.com/channel/UC-CSyyi47VX1lD9zyeABW3w/join

0:00 Introduction
1:10 Status of Top Vaccines
2:59 Storage Problem
3:53 Side Effects of Vaccine
7:20 Who will get it First?
8:13 Geopolitics of Vaccine
11:36 Russian & Chinese Vaccines
13:01 When will everything be normal again?

For more informative videos and discussion on important Indian and world issues-

Telegram channel to receive instant video updates: https://t.me/dhruvratheechannel

More videos by Dhruv Rathee
- Financial Education: https://www.youtube.com/playlist?list...
- Ground Reports from across the World: https://www.youtube.com/playlist?list...
- Indian Politics Videos: https://www.youtube.com/playlist?list...
- Educational Videos: https://www.youtube.com/playlist?list...
- Interviews by Dhruv Rathee: https://www.youtube.com/playlist?list...

Support on Patreon: https://www.patreon.com/dhruvrathee
Subscribe: http://www.youtube.com/dhruvrathee
Facebook: http://www.facebook.com/DhruvRatheePage
Twitter: http://www.twitter.com/dhruv_rathee
Instagram: http://www.instagram.com/dhruvrathee
शिक्षा - Education
Dhruv Rathee, Dhruv, Rathee
Sign in or sign up to post comments.
Be the first to comment